NIH Plans Closed Sessions for Brain and Heart Research Grants
Published Date: 3/11/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2025 to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. If you’re a researcher applying for grants in brain, immune, or heart studies, these reviews could impact your funding timeline and chances.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
NIH will review specific grant applications
The NIH Center for Scientific Review will hold closed meetings to review and evaluate grant applications on specific dates: April 7-8, April 8-9, April 9-10, April 10-11, April 16-17, April 24-25, and May 1-2, 2025. These meetings cover named study sections (for example, Clinical Neuroplasticity and Neurotransmitters; Molecular and Structural Immunology; Innate Immunity; Therapeutic Development and Preclinical Studies; Digestive System Host Defense; Cancer and Hematologic Disorders; HIV Molecular Virology).
Meetings closed to protect confidentiality
The meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (such as patentable material), and personal information associated with grant applications. The notice explicitly says disclosing that information would be a clearly unwarranted invasion of personal privacy.
Review panels will meet virtually
All listed review meetings are scheduled as virtual meetings (for example, the Clinical Neuroplasticity meeting on April 7-8, 2025 and the Therapeutic Development meeting on April 10-11, 2025). Each meeting entry in the notice explicitly states 'Meeting Format: Virtual Meeting.'
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12244 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
2026-12116 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important grant applications. These meetings protect private info and trade secrets while helping fund research on mice, drug development, and primate centers. Scientists and research groups applying for grants should watch for these dates as they impact funding decisions.
2026-12106 — Submission for OMB Review; 30-Day Comment Request; NIH Extramural Harassment Web Form (Office of the Director, Office of Extramural Research)
The NIH wants to keep their Extramural Harassment Web Form active so people working with NIH grants can safely report harassment. They’re asking the public to share thoughts by July 16, 2026, but no changes or costs are involved—just a smooth continuation. This helps keep NIH’s research community respectful and safe!
2026-12070 — Government Owned Inventions Available for License: Establishment and Characterization of the A1847 Human Ovarian Carcinoma Line
The National Cancer Institute is offering a special ovarian cancer cell line called A1847 for researchers to license and use. This cell line helps scientists study how ovarian cancer grows and find better treatments, especially for tough cases linked to BRCA1 gene problems. If you’re into cancer research, this is your chance to get a powerful tool starting now, with no big costs for licensing.
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Previous / Next Documents
Previous: 2025-03876 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding two closed virtual meetings in late March and early April 2025 to review important grant applications about infectious diseases and immunology. These meetings are private to protect sensitive information and personal privacy. Researchers applying for funding should note these dates as part of the grant review process, which helps decide where research money goes.
Next: 2025-03878 — NorthWestern Energy; Notice of Designation of Certain Commission Personnel as Non-Decisional
NorthWestern Energy’s Thompson Falls Hydroelectric Project is getting some special treatment! Two Commission staff members, Rachael Warden and Elizabeth Molloy, will help with settlement talks but won’t make any decisions or give advice on the project’s approval. This keeps things fair and clear as other staff handle the official reviews—no money or deadlines change, just a smart way to keep roles separate.